Gyre Therapeutics market cap GYRE

Share price times shares outstanding: what the whole company sells for, since 2011.

Gyre Therapeutics is worth $652.3M at the close on Oct 23, 2026, at $5.85 a share.

That is down 17% over the last year and up 532% over five years.

Its highest close in our data was $1.5B in Mar 2024.

Market cap over time

Year	End of year	Low	High	Change
2026 so far	$652.3M	$557.9M	$841.9M	−7%
2025	$699.4M	$623.5M	$1.1B	−40%
2024	$1.2B	$29.1M	$1.5B	+1690%
2023	$65M	$6.3M	$75.1M	+290%
2022	$16.7M	$11.3M	$62.6M	−42%
2021	$28.6M	$28.6M	$192.7M	−80%
2020	$139.4M	$45.4M	$145.6M	+71%
2019	$81.4M	$59.2M	$126.9M	−15%
2018	$95.5M	$65.2M	$343.5M	+62%
2017	$58.8M	$4.7M	$58.8M	+652%
2016	$7.8M	$7.8M	$33.4M	−78%
2015	$35.8M	$18.9M	$103.1M	−59%
2014	$87.8M	$78.4M	$171.8M	−37%
2013	$139M	$138M	$193.6M	−7%
2012	$149.2M	$133.4M	$245.8M	−20%
2011	$185.9M	$183.3M	$642.6M	n/a

Companies in Drug Manufacturers - General nearest Gyre Therapeutics' size, closest first, today.

Company	Market cap
GYREGyre Therapeutics	$652.3M
CRMDCorMedix	$611.9M
ZVRAZevra Therapeutics	$582.6M
IRWDIronwood Pharmaceuticals	$571.7M
COLLCollegium Pharmaceutical	$747.5M
PBYIPuma Biotechnology	$568.9M
ABUSArbutus Biopharma	$831M
ARVNArvinas	$477.3M
AMPHAmphastar Pharmaceuticals	$1.1B
OMEROmeros	$1.2B
PCRXPacira BioSciences	$1.5B
Peer median	$679.7M